Search Results for 'milestone payment'
-
Breaking News | Collaborations & Alliances | Drug Development
Cidara Therapeutics Receives $20M Milestone Payment Following FDA Approval of REZZAYO
Eligible to receive up to an additional $47 million in milestones from multiple existing partnerships based on successful completion of activities.04.24.23
-
Breaking News | Collaborations & Alliances | Drug Development
CNS, WPD Pharma to Develop Coronavirus Candidates
To develop several preclinical drug candidates including WP1122, which is being tested on a range of viruses including coronavirus03.23.20
-
Breaking News | Collaborations & Alliances | Drug Development
Evotec Earns Bayer Milestone
To advance a further program from the endometriosis alliance into Phase I development01.30.20
-
Breaking News | Collaborations & Alliances
AbbVie, Scripps Collaborate on New Therapeutics
To develop new therapies for a range of diseases, including areas of oncology, immunology, neurology and fibrosis.12.09.19
-
Breaking News | Collaborations & Alliances | Drug Development | Trials & Filings
Roche’s Risdiplam for SMA Granted Priority Review
FDA filing triggers $15M milestone to development partner PTC Therapeutics11.25.19
-
Drug Development | Industry News
-
Breaking News | Collaborations & Alliances | Drug Development
Genentech Selects Affimed Target in Immunotherapy Alliance
Genentech is responsible for clinical development and commercialization worldwide11.08.19
-
Collaborations & Alliances | Drug Development
CytomX Therapeutics Announces Second Target Selection with AbbVie
Multi-Program oncology collaboration triggers $10 million milestone payment to CytomX07.09.19
-
Collaborations & Alliances | Drug Development | Drug Discovery
Oxford Bio Receives Boehringer Milestone
Advances immuno-oncology programs leveraging the OGAP target discovery platform06.26.19
-
Bio News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | R&D
BioAtla & BeiGene Enter Development Pact
Agreement also covers the manufacturing and commercialization of BioAtla’s investigational CAB CTLA-4 antibody (BA3071)04.09.19
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Gliknik Receives $15M Milestone from Pfizer
Follows start of Phase 1 trial for Pfizer candidate PF-0675534702.20.19
-
Breaking News | Drug Development | Industry News
Nestlé Health Licenses Codexis’ CDX-6114
Novel, oral enzyme for phenylketonuria is Codexis’ first internally developed biotherapeutic candidate02.19.19
-
Bio News | Collaborations & Alliances | Industry News | R&D
CTI BioPharma Receives $10M Milestone from Teva
The payment was triggered by the achievement of sales milestones for TRISENOX (arsenic trioxide)02.11.19
-
Biologics, Proteins, Vaccines | Breaking News | Industry News
Orgenesis Plans U.S. Expansion of Masthercell Subsidiary
Receives $6.6 million milestone payment from Great Point Partners into Masthercell Global01.28.19
-
Breaking News | Clinical Trials | Collaborations & Alliances | Drug Development
Evotec Earns Second Genome Milestone
Initiates Phase II study of SGM-1019, a first-in-class oral therapeutic for the treatment of nonalcoholic steatohepatitis01.24.19
-
Bio News | Collaborations & Alliances | Industry News
Evotec, Celgene Collaboration Reaches Milestone
Resulting in Celgene designating a program and triggering a payment of $ 14M to Evotec01.08.19
-
ProBioGen Achieves Merus Milestone
Betta Pharmaceuticals to develop and commercialize in China Merus’ MCLA-12901.03.19
-
Breaking News | Collaborations & Alliances | Industry News
Recro Pharma Amends IV Meloxicam License Agreement with Alkermes
Reduces 2019 cash requirements by $30 Million; extends approval milestone payments over seven years12.26.18
-
Bio News | Collaborations & Alliances | Industry News
AMAG Acquires Perosphere
AMAG will acquire global rights to Perosphere's ciraparantag, a next generation anticoagulant reversal agent12.13.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
iDD Biotech Receives Second Milestone
Milstone was initiated after its partner, Genmab, started a Phase I/IIa trial of GEN102912.04.18
-
Bio News | Collaborations & Alliances | Industry News
Merrimack Receives $5M Milestone from Shire
Triggered by the sale of ONIVYDE in the first major non-European, non-Asian country09.24.18
-
Bio News | Collaborations & Alliances | Industry News
Neurimmune Achieves Milestone in Ono Collaboration
Focused on the development of human-derived antibodies against a novel therapeutic target for neurodegenerative diseases09.18.18
-
Breaking News | Collaborations & Alliances | Drug Development
Agenus Achieves Incyte Milestone
Initiation of a Phase I trial of INCAGN2385 triggers $5M payment09.17.18
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Clinical Trials | Drug Development | Industry News
Sirona Biochem Receives $500,000 Milestone from Wanbang
CFDA approves Phase I clinical trial for Sirona's SGLT-2 inhibitor08.29.18
-
Bio News | Collaborations & Alliances | Industry News
Amneal, JSP Enter Supply Agreement
The 10 year license & supply deal is for Levothyroxine sodium tablets08.20.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Industry News
Agenus Receives Second Milestone from Merck
Merck initiated a Phase I clinical trial of an antibody candidate discovered by Agenus, sparking a $4M milestone payment08.20.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Discovery | Industry News | R&D
Agenus Receives Merck Milestone
After Merck's initiation of a Phase I clinical trial of an undisclosed antibody candidate discovered by Agenus08.16.18
-
Collaborations & Alliances | Industry News
Pfenex Receives Merck Milestone Payment
As a result of an agreement originally signed in 200707.12.18
-
Collaborations & Alliances | Drug Development | Industry News
BioMarin Receives Pfizer Milestone Payments
Totaling $20 million, the payments were triggered by the FDA's acceptance of Pfizer's NDA for talazoparib06.12.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News
Bicycle Therapeutics, AstraZeneca Expand Collaboration
The 2016 partnership will now include additional targets in respiratory and cardio-metabolic diseases05.29.18
-
Biologics, Proteins, Vaccines | Collaborations & Alliances | Drug Development
ProBioGen Achieves Merus Milestone
Phase I trial will leverage GlymaxX cancer cell-killing enhancement antibody technology05.24.18
-
Bio News | Collaborations & Alliances | Industry News
Portola Receives $100M Milestone
From HealthCare Royalty Partners (HCR) following the FDA's approval of Andexxa05.24.18
-
Bio News | Collaborations & Alliances | Drug Discovery | Industry News
ANI Pharmaceuticals to Aquire Portfolio of Products
Through agreement with Amneal and Impax for an undisclosed cash consideration, with a $1.7B estimated market value05.01.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News | R&D
Catalyst Receives $1.5M in Milestones
After two triggering events for its neuronal nicotinic receptor (NNR) asset TC-649903.26.18
-
Bio News | Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing
Merus, Ono Pharma Enter New Agreement
For Merus’ Biclonics® technology platform to generate a bispecific antibody that treats autoimmune diseases03.14.18
-
Collaborations & Alliances | Drug Development | Industry News | Trials & Filings
Five Prime Therapeutics Triggers $5M Milestone
For the first IND to the FDA under Bristol-Myers Squibb collaboration01.08.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
APEIRON, Evotec Receive First Milestone from Sanofi
Under a 3-party alliance signed in August 201501.08.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Kowa Pays CymaBay $5M Milestone
For the initiation of a study evaluating the pharmacokinetics (PK) of arhalofenate in subjects with renal impairment01.08.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Inovio Receives Milestone from MedImmune
After a satisfactory completion of a phase 1 safety review01.08.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Alligator Bioscience To Receive $6M Milestone Payment
As part of their partnership agreement with Janssen01.03.18
-
Bio News | Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Generex Receives $700M Payment from Shenzhen BioScien
The upfront payment was for their license and research agreement focusing on Antigen Express AE3701.02.18
-
Collaborations & Alliances | Drug Development | Industry News
Summit Therapeutics Grants Eurofarma Rights in Latin America
For the licensing and commercialization for precision antibiotic ridinilazole12.27.17
-
Collaborations & Alliances | Drug Development
-
Collaborations & Alliances | Drug Development
-
Clinical Trials | Collaborations & Alliances | Drug Development | Industry News
Symphogen Receives $5M Milestone from Genentech
The payment is related to a potential treatment of Staphylococcus aureus infections12.01.17
-
Bio News | Collaborations & Alliances | Drug Development | Industry News
Genmab Achieves $20M Janssen Milestone
The daratumumab collaboration progress is based on a study of the drug in a disease other than multiple myeloma11.30.17
-
Collaborations & Alliances | Drug Development | Drug Discovery | Industry News | Laboratory Testing
CytomX Receives FDA Acceptance of Investigational New Drug Application
The IND is for a CTLA-4 Probody therapeutic11.28.17
-
Collaborations & Alliances | Industry News
Lead Pharma Achieves Third Milestone in Sanofi Partnership
The collaboration agreement focuses around the treatment of a broad range of autoimmune disorders11.21.17
-
Collaborations & Alliances | Industry News
Genmab to Receive $50M Milestone After DARZALEX Sales Soar
Janssen has confirmed that the drug reached $1B in sales in a calendar year11.17.17
-
Collaborations & Alliances
Argos Therapeutics Receives $1.5M Milestone
The payment was made after a successful transfer of technology related to the manufacturing of Rocapuldencel-T11.07.17
